BioNJ BioPartnering Conference 2026: Biotech & Partnering
The BioNJ BioPartnering Conference 2026, scheduled for May 12, 2026, in Jersey City, NJ, will connect biotech companies, investors, and industry experts. The conference features company presentations, startup pitches, and 1:1 partnering opportunities.
Intelligence Snapshot
Executive Summary
BioNJ BioPartnering Conference 2026 will be held on May 12, 2026, in Jersey City, NJ.
Key Insights
-
The conference focuses on company presentations, startup pitches, and 1:1 partnering…
The conference focuses on company presentations, startup pitches, and 1:1 partnering opportunities.
-
As of April 22, 2026, no specific data readouts or trial results have been announced for…
As of April 22, 2026, no specific data readouts or trial results have been announced for the conference.
- Confirmed sessions include a panel discussion on evolving FDA approval strategies.
Market Impact
| Regulatory | medium |
|---|---|
| Commercial | medium |
| Competitive | low |
| Investment | low |
Executive Scorecard
Heuristic scores · directional, not investment adviceContents4 sections
Key Takeaways
- BioNJ BioPartnering Conference 2026 will be held on May 12, 2026, in Jersey City, NJ.
- The conference focuses on company presentations, startup pitches, and 1:1 partnering opportunities.
- As of April 22, 2026, no specific data readouts or trial results have been announced for the conference.
- Confirmed sessions include a panel discussion on evolving FDA approval strategies.
The BioNJ BioPartnering Conference 2026 is scheduled for May 12, 2026, at the Liberty Science Center in Jersey City, NJ. This premier partnering event aims to connect biotech companies, investors, and industry experts through company presentations, startup pitches, and one-on-one partnering meetings.
The BioNJ BioPartnering Conference is a key event for the New Jersey biotech community, providing a platform for networking and potential collaborations. It attracts a diverse range of participants, from emerging startups to established pharmaceutical companies, all seeking to advance their research and business objectives.
Key Schedule Milestones (Pre-Conference Preparation)
Presenting companies followed a structured timeline leading up to the conference:
- Notifications to selected presenters: By March 16, 2026.
- Mandatory Information Session and Pitch Workshop: March 23, 2026.
- Free coaching sessions: April 6–17, 2026 (required for 2-minute startup pitches; optional/recommended for 8-minute company presentations).
- Final presentation slide decks due: No later than April 24, 2026.
- 1:1 Partnering Platform opens: April 2026.
Confirmed Conference Sessions
- Evolving FDA Approval Strategies: Maximizing Value, Minimizing Risk, and Navigating Regulatory Trends panel: Featuring Jacqueline Berman (Morgan Lewis).
- Opening remarks by David Schwartz (Morgan Lewis).
- Startup Pitch Presentations (2 minutes each) and Company Presentations (8 minutes each).
Presenting Companies Status
Company presenters were announced on April 13, 2026, via the BioNJ News Center. Applicant notifications occurred by March 16, 2026. As of April 22, 2026, a detailed list of presenting companies or specific data on their biotech drugs is not available.
Related Biotech News (No Direct Conference Link)
While no direct links to the conference are available, recent news includes:
- Insmed planning an sNDA filing for ARIKAYCE (amikacin liposome inhalation suspension) in H2 2026 for MAC lung disease.
- Kelun-Biotech presented Sacituzumab Tirumotecan (Sac-TMT) data at the 2026 SGO (Society of Gynecologic Oncology).
The conference agenda and list of presenting companies may evolve. Check the BioNJ News Center for the latest updates.
Market & Investor Implications
The BioNJ BioPartnering Conference provides a venue for companies to attract investment and forge strategic partnerships. Investors attending the conference gain early access to innovative technologies and potential deals within the New Jersey biotech sector.
What to Watch Next
Keep an eye on the BioNJ News Center for updates on presenting companies and conference highlights following the event. Further announcements regarding collaborations and investment deals may emerge in the weeks following the conference.
Frequently Asked Questions
-
When and where is the BioNJ BioPartnering Conference 2026 taking place?
The conference is scheduled for May 12, 2026, at the Liberty Science Center in Jersey City, NJ.
-
What is the focus of the BioNJ BioPartnering Conference?
The conference focuses on company presentations, startup pitches, and 1:1 partnering opportunities within the biotech industry.
-
Are there any specific data readouts or trial results being announced at the conference?
As of April 22, 2026, no specific data readouts or trial results have been announced for the conference.
-
What are some of the confirmed sessions at the conference?
Confirmed sessions include a panel discussion on evolving FDA approval strategies and presentations from David Schwartz (Morgan Lewis).
-
How can I find out more about the presenting companies?
Check the BioNJ News Center for updates on presenting companies and conference highlights.
References
- BioNJ News Center. https://bionj.org/news-center/
- BioNJ PR Newswire. https://bionj.org/pr-newswire-new-jersey?rkey=20260413CN32458&filter=16219
- LifeSciences BC. https://lifesciencesbc.ca/resources/applications-open/
- Morgan Lewis Events. https://www.morganlewis.com/events/2026/05/bionj-2026-biopartnering-conference
- BioNJ BioPartnering Conference Presenting Companies. https://bionj.org/bionj-biopartnering-conference-presenting-companies/
- BioNJ Entrepreneur Exchange. https://bionj.org/event/entrepreneurs-exchange-a-monthly-meeting-for-founders-c-level-entrepreneurs/
Related coverage
Ask AI About biotech
Grounded in NovaPharmaNews intelligence. Pick a prompt to start.
Track biotech news weekly
FDA biotech news and regulatory updates, every Monday.
- Evidence strength
- 79/100
- Last verified
- Jun 18, 2026
- AI-assisted review
- Yes
- Editorial review
- Dr. Sarah Chen
High source quality · grounded in cited primary and secondary sources.
This article follows our editorial standards. Report a correction via editorial contact.
About the Author
Continue Your Research
Industry Reports & Whitepapers
- America's Innovation Engine: Small and Mid-Sized Biotechs Drive U.S. Clinical Trials, FDA Filings — Small and mid-sized biotechs drive U.S. biotech employment, clinical trials, FDA filings, and most i…
- GxP Environmental Monitoring Systems: A Guide for Small Biotechs — Essential guide for small biotechs on GxP environmental monitoring systems to ensure compliance and …